KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $955,386,737 | -21.6% | 5,650,167 | +0.6% | 0.08% | -18.6% |
Q2 2023 | $1,217,957,108 | -40.2% | 5,616,588 | -49.9% | 0.10% | +9.7% |
Q1 2023 | $2,036,578,922 | +101.1% | 11,212,172 | +117.6% | 0.09% | -7.9% |
Q4 2022 | $1,012,562,472 | +1.1% | 5,152,990 | +15.8% | 0.10% | -2.9% |
Q3 2022 | $1,001,210,000 | +76.6% | 4,451,209 | -0.7% | 0.10% | +82.5% |
Q2 2022 | $567,070,000 | -2.3% | 4,482,408 | -2.1% | 0.06% | +23.9% |
Q1 2022 | $580,607,000 | -3.1% | 4,579,281 | +0.1% | 0.05% | +4.5% |
Q4 2021 | $599,207,000 | +6.4% | 4,574,106 | -0.7% | 0.04% | -2.2% |
Q3 2021 | $563,221,000 | +5.9% | 4,604,106 | -1.3% | 0.04% | +7.1% |
Q2 2021 | $531,662,000 | -5.2% | 4,664,106 | 0.0% | 0.04% | -12.5% |
Q1 2021 | $560,766,000 | +18.3% | 4,664,106 | 0.0% | 0.05% | +14.3% |
Q4 2020 | $473,826,000 | +53.5% | 4,664,106 | +16.8% | 0.04% | +35.5% |
Q3 2020 | $308,691,000 | -29.3% | 3,992,386 | +1.9% | 0.03% | -35.4% |
Q2 2020 | $436,869,000 | +55.1% | 3,919,518 | +0.2% | 0.05% | +23.1% |
Q1 2020 | $281,693,000 | -4.2% | 3,912,406 | +0.3% | 0.04% | +21.9% |
Q4 2019 | $293,970,000 | +821.0% | 3,901,913 | +95.2% | 0.03% | +700.0% |
Q3 2019 | $31,917,000 | -12.5% | 1,998,591 | +4.8% | 0.00% | 0.0% |
Q2 2019 | $36,477,000 | – | 1,907,791 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |